Broadfin Healthcare Master Fund Ltd Insider Profile
4 Followers
Broadfin Healthcare Master Fund Ltd, Ten Percent Owner at Aegerion, holds 4.31M shares in BioDelivery (Ticker: BDSI), holds 0.00 shares in Aratana (Ticker: PETX), holds 1.50M shares in Novelion Therapeutics (Ticker: NVLNF). Most recently, Broadfin Healthcare Master Fund Ltd Sold ― shares of BioDelivery on Dec 20, 2019 for an estimated value of 12.80M.
What was Broadfin Healthcare Master Fund Ltd’s latest transaction?
Broadfin Healthcare Master Fund Ltd latest transaction was an Informative Sell of $12.80M.
What was Broadfin Healthcare Master Fund Ltd's most profitable transaction?
Broadfin Healthcare Master Fund Ltd’s most profitable transaction was an Informative Buy of SCTL stock on September 18, 2014. The return on the trade was 448.50%.
What is Broadfin Healthcare Master Fund Ltd's role in Aegerion?
Broadfin Healthcare Master Fund Ltd's role in Aegerion is Ten Percent Owner.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.